MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1517/14740338.2015.1089232

Медицинская библиотека · Expert opinion on drug safety · 2015

The safety of liposome bupivacaine 2 years post-launch: a look back and a look forward.

Viscusi Eugene R

Редакционная статьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

The need for better post-surgical pain management continues to be unmet, despite clinicians' awareness and concern for many years. Opioids remain the standard of care because of their analgesic efficacy; however, opioid use is often associated with adverse effects and poor patient outcomes. Multimodal analgesic regimens have recently been endorsed as a way to provide adequate post-surgical pain control while reducing opioid consumption. Liposome bupivacaine is a liposomal formulation of bupivacaine indicated for a single administration into the surgical site. Based on the available clinical trial data compiled to date, as well as the author's review of publicly available post-marketing safety information, liposome bupivacaine may be a viable addition to currently available therapeutic options for post-surgical analgesia while reducing potential risks associated with use of opioid analgesics, and may represent a useful addition to the multimodal analgesic modalities currently used for post-operative pain management. The potential for its use in other areas is also being investigated. The purpose of this review is to examine the currently available post-marketing safety information on liposome bupivacaine.

Для цитирования: Viscusi Eugene R. The safety of liposome bupivacaine 2 years post-launch: a look back and a look forward.. Expert opinion on drug safety. 2015. DOI: 10.1517/14740338.2015.1089232.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.